| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.088 | 0.07 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |